| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0009 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |